According to the Canadian Venture Capital and Private Equity Association’s (CVCA) 2024 VC market overview, investments ...
AstraZeneca has unveiled plans to invest around ... AZ announced a C$500 million investment in its Global Clinical Hub in Mississauga, Ontario, to expand its research and clinical trials ...
Canadian VC saw $7.86 billion invested across 592 deals in 2024, per the CVCA, buoyed by later-stage megadeals while seed ...
which is funded by an annual grant from the Ontario Ministry of Health and the Ministry of Long-Term Care. Abdel-Qadir has received speaker honoraria from Amgen, AstraZeneca, and Jazz Pharmaceuticals.
Hosted on MSN2d
Today-History-Mar02
Today in History for March 2: ...
AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to oral anemia drug roxadustat. The two companies' relationship around ...
FibroGen sells its China unit to AstraZeneca for about $160M, strengthening its cash position and extending its financial runway into 2027. AstraZeneca gains full rights to roxadustat in China ...
The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May 30, 2024 to June 7, 2024, including manufacturing and ...
The World Ovarian Cancer Coalition (the Coalition) announced today the publication of a first-of-its-kind study that reveals the major socioeconomic burden ovarian cancer has on communities around the ...
Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile Healthcare & Pharmaceuticalscategory· February 20, 2025 AstraZeneca will buy longtime partner FibroGen's China unit ...
Maria joined AstraZeneca in 2017 as head of Respiratory, Inflammation & Autoimmunity in the Innovative Medicines and Early Development (IMED) Biotech Unit. In her role she leads early-stage ...